Advisory Board on Radiation and Worker Health: Notice of Charter Renewal, 44856 [E9-20958]
Download as PDF
<![CDATA[
44856
Federal Register / Vol. 74, No. 167 / Monday, August 31, 2009 / Notices
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Katharine Kripke,
Assistant Director, Vaccine Research
Program, Division of AIDS, NIAID, NIH,
6700B Rockledge Dr., Bethesda, MD
20892–7628, or call non-toll-free
number 301–402–0846, or E-mail your
request, including your address to
NIAIDsurvey@NIH.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: August 25, 2009.
J.J. McGowan,
Executive Officer, NIAID, National Institutes
of Health.
[FR Doc. E9–20882 Filed 8–28–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
cprice-sewell on DSK2BSOYB1PROD with NOTICES
Advisory Board on Radiation and
Worker Health: Notice of Charter
Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Advisory Board on Radiation and
Worker Health, Department of Health
and Human Services, has been renewed
for a 2-year period through August 3,
2011.
For information, contact Mr.
Theodore Katz, Executive Secretary,
Advisory Board on Radiation and
Worker Health, Department of Health
and Human Services, 1600 Clifton Road,
M/S E20, Atlanta, Georgia, 30341,
telephone 404/498–2533, or fax 404/
498–2570.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
VerDate Nov<24>2008
14:57 Aug 28, 2009
Jkt 217001
meetings and other committee
management activities, for both the CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: August 19, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–20958 Filed 8–28–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
AGENCY: Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
SUMMARY: The Department of Health and
Human Services (HHS) notifies Federal
agencies of the laboratories currently
certified to meet the standards of
Subpart C of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908),
on September 30, 1997 (62 FR 51118),
and on April 13, 2004 (69 FR 19644).
A notice listing all currently certified
laboratories is published in the Federal
Register during the first week of each
month. If any laboratory’s certification
is suspended or revoked, the laboratory
will be omitted from subsequent lists
until such time as it is restored to full
certification under the Mandatory
Guidelines.
If any laboratory has withdrawn from
the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end,
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://
www.workplace.samhsa.gov and https://
www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs.
Giselle Hersh, Division of Workplace
Programs, SAMHSA/CSAP, Room 2–
1042, One Choke Cherry Road,
Rockville, Maryland 20857; 240–276–
2600 (voice), 240–276–2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were developed
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
in accordance with Executive Order
12564 and section 503 of Public Law
100–71. Subpart C of the Mandatory
Guidelines, ‘‘Certification of
Laboratories Engaged in Urine Drug
Testing for Federal Agencies,’’ sets strict
standards that laboratories must meet in
order to conduct drug and specimen
validity tests on urine specimens for
Federal agencies. To become certified,
an applicant laboratory must undergo
three rounds of performance testing plus
an on-site inspection. To maintain that
certification, a laboratory must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories which claim to be in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A laboratory
must have its letter of certification from
HHS/SAMHSA (formerly: HHS/NIDA)
which attests that it has met minimum
standards.
In accordance with Subpart C of the
Mandatory Guidelines dated April 13,
2004 (69 FR 19644), the following
laboratories meet the minimum
standards to conduct drug and specimen
validity tests on urine specimens:
ACL Laboratories, 8901 W. Lincoln Ave.,
West Allis, WI 53227. 414–328–7840/800–
877–7016. (Formerly: Bayshore Clinical
Laboratory.)
ACM Medical Laboratory, Inc., 160 Elmgrove
Park, Rochester, NY 14624. 585–429–2264.
Advanced Toxicology Network, 3560 Air
Center Cove, Suite 101, Memphis, TN
38118. 901–794–5770/888–290–1150.
Aegis Analytical Laboratories, 345 Hill Ave.,
Nashville, TN 37210. 615–255–2400.
(Formerly: Aegis Sciences Corporation,
Aegis Analytical Laboratories, Inc.)
Baptist Medical Center-Toxicology
Laboratory, 9601 I–630, Exit 7, Little Rock,
AR 72205–7299. 501–202–2783. (Formerly:
Forensic Toxicology Laboratory Baptist
Medical Center.)
Clendo Reference Laboratory, Avenue Santa
Cruz #58, Bayamon, Puerto Rico 00959.
787–620–9095.
Clinical Reference Lab, 8433 Quivira Road,
Lenexa, KS 66215–2802. 800–445–6917.
Doctors Laboratory, Inc., 2906 Julia Drive,
Valdosta, GA 31602. 229–671–2281.
DrugScan, Inc., P.O. Box 2969, 1119 Mearns
Road, Warminster, PA 18974. 215–674–
9310.
DynaLIFE Dx,* 10150–102 St., Suite 200,
Edmonton, Alberta, Canada T5J 5E2. 780–
451–3702/800–661–9876. (Formerly:
Dynacare Kasper Medical Laboratories.)
ElSohly Laboratories, Inc., 5 Industrial Park
Drive, Oxford, MS 38655. 662–236–2609.
Gamma-Dynacare Medical Laboratories,* A
Division of the Gamma-Dynacare
Laboratory Partnership, 245 Pall Mall
Street, London, ONT, Canada N6A 1P4.
519–679–1630.
Kroll Laboratory Specialists, Inc., 1111
Newton St., Gretna, LA 70053. 504–361–
E:\FR\FM\31AUN1.SGM
31AUN1
]]>Agencies
[Federal Register Volume 74, Number 167 (Monday, August 31, 2009)]
[Notices]
[Page 44856]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20958]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Advisory Board on Radiation and Worker Health: Notice of Charter
Renewal
This gives notice under the Federal Advisory Committee Act (Pub. L.
92-463) of October 6, 1972, that the Advisory Board on Radiation and
Worker Health, Department of Health and Human Services, has been
renewed for a 2-year period through August 3, 2011.
For information, contact Mr. Theodore Katz, Executive Secretary,
Advisory Board on Radiation and Worker Health, Department of Health and
Human Services, 1600 Clifton Road, M/S E20, Atlanta, Georgia, 30341,
telephone 404/498-2533, or fax 404/498-2570.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the CDC and the Agency for Toxic Substances and Disease
Registry.
Dated: August 19, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-20958 Filed 8-28-09; 8:45 am]
BILLING CODE 4163-18-P
